Skin, Skin infections, inflammations
Top Medical Solutions for Uncommon Skin Conditions Now
Apr
In the realm of dermatology, uncommon skin conditions often pose significant challenges for both patients and healthcare providers. These rare disorders can be difficult to diagnose, and finding effective treatment options may require extensive research and specialized expertise. As medical science continues to advance, however, new solutions are emerging that offer hope for individuals struggling with these complex conditions.
This article explores the latest medical solutions for uncommon skin conditions, drawing on recent scientific research and expert insights. We will delve into innovative diagnostic techniques, novel topical treatments, systemic therapies for severe cases, laser and light-based interventions, complementary and alternative medicine approaches, surgical options for refractory cases, and future directions in research. By providing a comprehensive overview of these cutting-edge solutions, we aim to empower patients and healthcare providers with the knowledge they need to make informed decisions and achieve the best possible outcomes.
Overview of Uncommon Skin Conditions
Definition and prevalence
Uncommon skin conditions are rare dermatological disorders that affect a small percentage of the population. These conditions are often characterized by unique symptoms, such as unusual skin texture, color, or growths, and may have a significant impact on a patient’s quality of life. While the prevalence of each individual condition may vary, collectively, uncommon skin conditions affect a substantial number of people worldwide[1].
Classification of uncommon skin conditions
Uncommon skin conditions can be classified based on their underlying causes, such as genetic factors, autoimmune disorders, or environmental triggers. Some examples of rare genetic skin disorders include epidermolysis bullosa, ichthyosis, and xeroderma pigmentosum. Autoimmune conditions like scleroderma and dermatomyositis also fall under the category of uncommon skin disorders. Environmental factors, such as exposure to certain chemicals or medications, can also lead to the development of rare skin conditions like Stevens-Johnson syndrome[2].
Impact on quality of life
Patients with uncommon skin conditions often experience significant physical discomfort, emotional distress, and social stigma. Symptoms like chronic itching, pain, and visible skin abnormalities can lead to sleep disturbances, anxiety, depression, and difficulty in daily functioning. Moreover, the lack of public awareness and understanding of these conditions can result in social isolation and discrimination, further impacting the patient’s quality of life[3].
Challenges in diagnosis and treatment
Diagnosing and treating uncommon skin conditions can be challenging due to their rarity and the lack of widespread expertise among healthcare providers. Patients may face delays in receiving an accurate diagnosis, as many primary care physicians and general dermatologists may not be familiar with these conditions. Furthermore, limited research funding and the small patient population can hinder the development of targeted therapies and evidence-based treatment guidelines.
Advances in Diagnostic Techniques
Dermoscopy and its applications
Dermoscopy, also known as dermatoscopy or epiluminescence microscopy, is a non-invasive diagnostic technique that allows for the magnified visualization of skin lesions. This technique has proven invaluable in the early detection and differentiation of various skin conditions, including uncommon disorders. Dermoscopy enables dermatologists to identify specific morphological features that may not be visible to the naked eye, aiding in the accurate diagnosis of conditions such as pigmented purpuric dermatosis and lichen planus pigmentosus[4].
Confocal microscopy for in-depth analysis
Reflectance confocal microscopy (RCM) is an advanced imaging technique that provides high-resolution, real-time images of the skin at a cellular level. This technology allows dermatologists to perform non-invasive, in vivo “virtual biopsies,” reducing the need for physical tissue sampling. RCM has shown great potential in the diagnosis of uncommon skin conditions, such as cutaneous T-cell lymphoma and Darier’s disease, by revealing characteristic cellular patterns that aid in differentiation from other disorders[5].
Genetic testing for hereditary skin disorders
Genetic testing has emerged as a crucial tool in diagnosing hereditary skin disorders, many of which are considered uncommon. By analyzing a patient’s DNA, dermatologists can identify specific gene mutations responsible for conditions such as epidermolysis bullosa, ichthyosis, and Hailey-Hailey disease. This information not only confirms the diagnosis but also helps in predicting disease severity, guiding treatment decisions, and providing genetic counseling to affected families[6].
Artificial intelligence in skin condition recognition
Artificial intelligence (AI) and machine learning algorithms are revolutionizing the field of dermatology by assisting in the recognition and classification of skin conditions, including rare disorders. AI-based systems can analyze vast amounts of clinical images and data, learning to identify patterns and features associated with specific conditions. These tools can serve as valuable aids to dermatologists, particularly in the diagnosis of uncommon skin disorders, by providing objective and consistent assessments and suggesting potential differential diagnoses.
Novel Topical Treatments
Targeted immunomodulators
Topical immunomodulators are a class of medications that target specific components of the immune system to reduce inflammation and regulate skin cell growth. These drugs have shown promise in treating various uncommon skin conditions, such as atopic dermatitis, psoriasis, and vitiligo. For example, topical Janus kinase (JAK) inhibitors, such as ruxolitinib and tofacitinib, have demonstrated efficacy in managing atopic dermatitis and vitiligo by suppressing the overactive immune response in the skin[7].
Advanced formulations for enhanced delivery
Innovative drug delivery systems have been developed to improve the efficacy and tolerability of topical treatments for uncommon skin conditions. Nanoparticle-based formulations, such as liposomes and nanoemulsions, can enhance the penetration of active ingredients into the skin, allowing for targeted delivery and reduced systemic absorption. Additionally, controlled-release formulations, such as hydrogels and microemulsions, can provide sustained drug release over an extended period, minimizing the need for frequent applications and improving patient adherence[8].
| Pros | Cons |
|---|---|
| Targeted action on specific skin components | May require long-term use for optimal results |
| Improved drug delivery and penetration | Potential for local side effects, such as irritation or allergic reactions |
| Reduced systemic absorption and adverse effects | Limited data on long-term safety and efficacy for some treatments |
| Non-invasive and convenient for patients | May be expensive compared to conventional topical therapies |
Combination therapies for synergistic effects
Combining multiple topical agents with complementary mechanisms of action can lead to synergistic effects and improved treatment outcomes for uncommon skin conditions. For instance, the combination of a topical retinoid, such as tazarotene, with a topical corticosteroid has shown enhanced efficacy in treating disorders like psoriasis and lichen planus. By targeting multiple pathways simultaneously, combination therapies can provide more comprehensive disease control and minimize the risk of adverse effects associated with long-term monotherapy[9].
Personalized compounding for rare conditions
Customized compounding of topical medications is an essential strategy for treating rare skin conditions that may not have commercially available treatments. Compounding pharmacies can prepare personalized formulations tailored to a patient’s specific needs, incorporating unique combinations of active ingredients, bases, and vehicles. This approach allows dermatologists to optimize treatment based on the individual’s skin type, condition severity, and response to previous therapies, ultimately improving outcomes for patients with uncommon skin disorders.
Systemic Therapies for Severe Cases
Immunosuppressive agents
In severe cases of uncommon skin conditions, systemic immunosuppressive agents may be necessary to control inflammation and prevent disease progression. Medications such as methotrexate, cyclosporine, and mycophenolate mofetil have been used off-label to treat various disorders, including severe psoriasis, atopic dermatitis, and pemphigus vulgaris. These agents work by inhibiting the activation and proliferation of immune cells, thereby reducing the inflammatory response in the skin. However, their use requires close monitoring due to potential side effects, such as liver toxicity, renal dysfunction, and increased risk of infections[10].
Biologics and targeted therapies
Biologic agents, which are engineered proteins that target specific components of the immune system, have revolutionized the treatment of severe and refractory cases of uncommon skin conditions. For example, TNF-α inhibitors, such as adalimumab and infliximab, have shown remarkable efficacy in managing severe plaque psoriasis and hidradenitis suppurativa. Interleukin inhibitors, like ustekinumab and secukinumab, have also proven effective in treating psoriasis and other inflammatory skin disorders[11]. These targeted therapies offer a more precise approach to disease management, minimizing the risk of broad immunosuppression associated with traditional systemic agents.
Oral retinoids for keratinization disorders
Oral retinoids, such as acitretin and isotretinoin, are valuable options for treating severe keratinization disorders, including psoriasis, ichthyosis, and Darier’s disease. These medications work by regulating cell growth and differentiation, normalizing the excessive production of keratin in the skin. Oral retinoids have been shown to significantly improve skin texture, reduce scaling, and alleviate associated symptoms in patients with severe manifestations of these conditions. However, their use is limited by potential adverse effects, such as teratogenicity, dyslipidemia, and mucocutaneous dryness, necessitating close monitoring and contraceptive use in female patients of childbearing age[12].
Emerging therapies and future directions
As our understanding of the molecular mechanisms underlying uncommon skin conditions continues to expand, novel systemic therapies are being developed to target specific pathways involved in disease pathogenesis. For instance, small molecule inhibitors of signaling pathways, such as the JAK-STAT and phosphodiesterase type 4 (PDE4) pathways, are showing promise in the treatment of various inflammatory skin disorders. Additionally, cell-based therapies, such as autologous stem cell transplantation, are being explored as potential options for severe and recalcitrant cases of conditions like scleroderma and epidermolysis bullosa.
Laser and Light-based Interventions
Pulsed dye laser for vascular lesions
Pulsed dye laser (PDL) has emerged as a highly effective treatment for vascular lesions associated with uncommon skin conditions, such as port-wine stains, telangiectasia, and angiokeratomas. PDL works by selectively targeting hemoglobin in blood vessels, causing coagulation and subsequent clearance of the lesion. This non-invasive approach has shown remarkable results in improving the appearance of vascular lesions, with minimal risk of scarring or pigmentary changes. PDL treatment protocols can be tailored to the specific characteristics of the lesion, such as depth and diameter of blood vessels, to optimize outcomes[13].
Fractional laser resurfacing for textural irregularities
Fractional laser resurfacing has revolutionized the treatment of textural irregularities associated with various uncommon skin conditions, including scleroderma, lichen sclerosus, and poikiloderma of Civatte. This technology creates microscopic thermal zones of controlled injury in the skin, stimulating collagen remodeling and tissue regeneration. Fractional lasers can be either ablative (e.g., CO2 and erbium:YAG) or non-ablative (e.g., 1550 nm erbium-doped fiber laser), depending on the depth of penetration and desired level of improvement. These treatments have shown significant promise in improving skin texture, elasticity, and overall appearance, with minimal downtime and adverse effects[14].
| Intervention | Indications | Mechanism of Action |
|---|---|---|
| Pulsed dye laser | Vascular lesions (e.g., port-wine stains, telangiectasia) | Selective photothermolysis of hemoglobin |
| Fractional laser resurfacing | Textural irregularities (e.g., scleroderma, lichen sclerosus) | Creation of microscopic thermal zones to stimulate collagen remodeling |
| Intense pulsed light | Pigmentary disorders (e.g., melasma, post-inflammatory hyperpigmentation) | Selective photothermolysis of melanin |
| Photodynamic therapy | Actinic keratosis, Bowen’s disease, superficial basal cell carcinoma | Light activation of photosensitizing agents to generate reactive oxygen species |
Intense pulsed light for pigmentary disorders
Intense pulsed light (IPL) is a broadband light source that has shown efficacy in treating pigmentary disorders associated with uncommon skin conditions, such as melasma, post-inflammatory hyperpigmentation, and Becker’s nevus. IPL emits polychromatic light in the visible and near-infrared spectrum, which is preferentially absorbed by melanin in the skin. This selective photothermolysis leads to the destruction of pigmented cells and gradual clearance of the lesion. IPL treatments are generally well-tolerated, with minimal risk of complications, and can be customized based on the patient’s skin type and the characteristics of the pigmentary disorder[15].
Photodynamic therapy for precancerous lesions
Photodynamic therapy (PDT) is a promising intervention for treating precancerous lesions, such as actinic keratosis and Bowen’s disease, which may be associated with certain uncommon skin conditions. PDT involves the application of a photosensitizing agent, typically aminolevulinic acid or methyl aminolevulinate, followed by exposure to a specific wavelength of light. This combination generates reactive oxygen species that selectively destroy abnormal cells while preserving surrounding healthy tissue. PDT has demonstrated high efficacy rates and excellent cosmetic outcomes, making it a valuable option for managing precancerous lesions in sensitive areas, such as the face and scalp.
Complementary and Alternative Medicine
Herbal and botanical remedies
Herbal and botanical remedies have been used for centuries to treat various skin conditions, including uncommon disorders. Some promising agents include aloe vera, which has anti-inflammatory and wound-healing properties, and licorice root extract, which contains glabridin, a compound with skin-lightening effects. Other botanicals, such as green tea, chamomile, and witch hazel, have been reported to have anti-inflammatory, antimicrobial, and soothing properties that may benefit individuals with certain skin conditions. However, it is essential to note that the efficacy and safety of these remedies have not been extensively studied in the context of uncommon skin disorders, and they should be used with caution, particularly in patients with known allergies or sensitivities[16].
Dietary modifications and nutritional supplements
Dietary modifications and nutritional supplements may play a role in managing some uncommon skin conditions. For example, a gluten-free diet has been suggested to improve symptoms in patients with dermatitis herpetiformis, a rare autoimmune blistering disorder associated with celiac disease. Omega-3 fatty acids, found in fish oil and flaxseed oil, have been shown to have anti-inflammatory effects and may be beneficial for individuals with inflammatory skin conditions, such as psoriasis and atopic dermatitis. Vitamin D supplementation has also been proposed as a potential adjunctive therapy for patients with vitiligo, as vitamin D deficiency has been linked to the development and progression of this condition[17].
Mind-body interventions for stress management
Mind-body interventions, such as meditation, deep breathing exercises, and yoga, may be valuable tools for managing stress and promoting overall well-being in patients with uncommon skin conditions. Stress has been implicated as a potential trigger or exacerbating factor for various skin disorders, including psoriasis, atopic dermatitis, and rosacea. By incorporating stress-reduction techniques into their self-care routine, patients may experience improvements in skin symptoms and quality of life. Additionally, cognitive-behavioral therapy (CBT) has been shown to be effective in helping patients cope with the psychological impact of living with a chronic skin condition, such as anxiety, depression, and social isolation[18].
Acupuncture and traditional Chinese medicine
Acupuncture and traditional Chinese medicine (TCM) have been used to treat various skin conditions for centuries. These approaches focus on restoring balance and harmony within the body to promote healing and prevent disease.In TCM, skin disorders are often attributed to imbalances in specific organ systems or the flow of qi (vital energy) and blood. Acupuncture involves the insertion of fine needles into specific points on the body to stimulate healing and regulate bodily functions. While some studies have suggested potential benefits of acupuncture and TCM for certain skin conditions, such as atopic dermatitis and psoriasis, more research is needed to establish their efficacy and safety in the context of uncommon skin disorders.
Surgical Options for Refractory Cases
Excisional surgery for localized lesions
In some cases of uncommon skin conditions, particularly those with localized, well-defined lesions, excisional surgery may be a viable option when other treatments have failed. This approach involves the complete removal of the affected skin and underlying tissue, followed by closure of the surgical wound. Excisional surgery can be an effective way to eliminate stubborn lesions, reduce the risk of malignant transformation, and improve cosmetic appearance. However, it is important to consider factors such as the size and location of the lesion, potential for scarring, and the patient’s overall health before proceeding with surgery[19].
Mohs micrographic surgery for high-risk skin cancers
Mohs micrographic surgery is a specialized surgical technique used to treat high-risk skin cancers, such as basal cell carcinoma and squamous cell carcinoma, which may occur in the context of certain uncommon skin conditions. This procedure involves the sequential removal and microscopic examination of thin layers of skin tissue until all cancerous cells have been eliminated. Mohs surgery offers the highest cure rates and maximal preservation of healthy tissue, making it an excellent option for tumors located in cosmetically sensitive or functionally critical areas, such as the face, ears, and hands. In addition, this technique can be particularly beneficial for patients with a history of recurrent or aggressive skin cancers[20].
Tissue expansion and flap reconstruction for extensive defects
In some cases of uncommon skin conditions, extensive surgical excision may be necessary to remove large, deep, or recurrent lesions. This can result in significant tissue defects that require advanced reconstructive techniques, such as tissue expansion or flap reconstruction. Tissue expansion involves the gradual stretching of adjacent healthy skin using an implanted expandable device, which can create additional skin for coverage of the surgical defect. Flap reconstruction, on the other hand, involves the transfer of skin, subcutaneous tissue, and sometimes muscle from a nearby or distant donor site to cover the defect. These techniques can help restore both function and cosmetic appearance in patients with extensive surgical wounds[21].
Collaboration with other surgical specialties
The management of uncommon skin conditions may sometimes require collaboration with other surgical specialties, depending on the specific characteristics and location of the lesions. For example, oculoplastic surgeons may be involved in the treatment of eyelid or periorbital lesions, while oral and maxillofacial surgeons may assist with the management of oral or perioral manifestations. In cases where skin conditions affect the genitalia or perianal region, gynecologic or colorectal surgeons may be consulted. This multidisciplinary approach ensures that patients receive comprehensive, specialized care tailored to their unique needs, optimizing outcomes and quality of life.
Future Directions and Research
Targeted therapies for specific molecular pathways
As our understanding of the molecular basis of uncommon skin conditions continues to grow, the development of targeted therapies that address specific pathogenic pathways has become an increasingly promising area of research. For example, the identification of mutations in the PTPN14 gene in patients with punctate palmoplantar keratoderma type I has led to the exploration of targeted therapies that could potentially correct the underlying genetic defect. Similarly, the discovery of IL-36 receptor antagonist deficiency as a cause of generalized pustular psoriasis has opened up new avenues for the development of IL-36-targeted therapies. As more molecular targets are identified, personalized medicine approaches may become increasingly feasible for patients with rare skin disorders[22].
Gene therapy for genetic skin disorders
Gene therapy has emerged as a potential treatment strategy for genetic skin disorders, particularly those caused by single-gene mutations. This approach involves the introduction of a functional copy of the defective gene into the patient’s cells, either ex vivo (outside the body) or in vivo (directly into the body). Researchers have made significant progress in developing gene therapy techniques for conditions such as epidermolysis bullosa, a group of inherited blistering disorders caused by mutations in genes encoding structural proteins of the skin. While challenges remain, such as ensuring the long-term expression of the transferred gene and minimizing the risk of immune reactions, gene therapy holds promise as a future treatment option for patients with genetic skin conditions[23].
Stem cell-based therapies for regenerative medicine
Stem cell-based therapies have generated considerable interest in the field of regenerative medicine, with potential applications for the treatment of various skin conditions. These approaches harness the unique properties of stem cells, such as their ability to self-renew and differentiate into multiple cell types, to promote tissue repair and regeneration. Researchers are exploring the use of both adult stem cells (e.g., mesenchymal stem cells) and pluripotent stem cells (e.g., induced pluripotent stem cells) for the treatment of conditions such as chronic wounds, vitiligo, and scleroderma. While further research is needed to optimize these therapies and address safety concerns, stem cell-based approaches may offer new hope for patients with challenging or refractory skin conditions[24].
International collaborations and patient registries
Given the rarity of many uncommon skin conditions, international collaborations and patient registries are essential for advancing research and improving patient care. By pooling resources and expertise, researchers can conduct larger, more robust studies to better understand the natural history, epidemiology, and treatment outcomes of these conditions. Patient registries, such as the International Registry of Werner Syndrome and the National Registry of Ichthyosis and Related Disorders, play a crucial role in collecting clinical data, facilitating research, and connecting patients with clinical trials and expert care. Strengthening these collaborative efforts will be key to driving progress in the diagnosis, management, and treatment of uncommon skin disorders in the years to come.
Frequently Asked Questions
Some examples of uncommon skin conditions include Hailey-Hailey disease, Darier disease, pemphigus vulgaris, and epidermolysis bullosa. These conditions are rare and can cause a variety of symptoms, such as blistering, rashes, and skin fragility.
Diagnosing uncommon skin conditions often involves a combination of clinical examination, skin biopsy, and specialized tests such as immunofluorescence studies or genetic testing. A dermatologist with expertise in rare skin disorders is best equipped to make an accurate diagnosis.
Treatment options for uncommon skin conditions vary depending on the specific disorder and its severity. Treatments may include topical or systemic medications, phototherapy, laser therapy, or surgery in some cases. Supportive care, such as wound care and pain management, is also essential for many patients.
Most uncommon skin conditions are not contagious, as they are often caused by genetic mutations or autoimmune disorders. However, some rare infectious skin diseases, such as leprosy or cutaneous tuberculosis, can be transmitted from person to person.
Some complementary and alternative medicine approaches, such as herbal remedies, dietary modifications, and stress-reduction techniques, may offer potential benefits for patients with uncommon skin conditions. However, it is crucial to consult with a dermatologist before incorporating these therapies into a treatment plan to ensure safety and avoid potential interactions with conventional treatments.
If you suspect you have an uncommon skin condition, it is essential to seek care from a dermatologist, preferably one with expertise in managing rare skin disorders. They can provide an accurate diagnosis and develop an individualized treatment plan based on your specific needs and the characteristics of your condition.
Yes, there are various support groups and resources available for people with uncommon skin conditions. Organizations such as the National Organization for Rare Disorders (NORD) and the Foundation for Ichthyosis & Related Skin Types (FIRST) provide information, support, and advocacy for patients and families affected by rare skin disorders. Connecting with others who share similar experiences can be a valuable source of emotional support and practical advice.
Reference list
- Nguyen T, Zuniga R. Skin conditions: rare and genetic. FP Essentials. 2017;461:11-17.
- Rosman IS, Hepper DM. Genetic skin disorders: an update for dermatologists. Current Opinion in Pediatrics. 2019;31(4):505-511.
- Moure ER, Romiti R, Machado MC, Valente NY. Hereditary epidermolysis bullosa: clinical and therapeutic aspects. Anais Brasileiros de Dermatologia. 2010;85(3):355-366.
- Banning M, Buttar HS. Skin disorders: clinical approaches to what’s common and what’s not. Journal of Clinical Research and Medicine. 2020;3(2):1-12.
- Calonje E, Brenn T, Lazar A, Billings S. McKee’s Pathology of the Skin. 5th ed. Edinburgh: Elsevier; 2020.
- Intong LR, Murrell DF. Inherited epidermolysis bullosa: new diagnostic criteria and classification. Clinics in Dermatology. 2012;30(1):70-77.
- Fine JD, Eady RA, Bauer EA, et al. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. Journal of the American Academy of Dermatology. 2008;58(6):931-950.
- Lee JY, Liu L, Hsu CK, et al. Mutations in KLHL24 add to the molecular heterogeneity of epidermolysis bullosa simplex. Journal of Investigative Dermatology. 2017;137(6):1378-1380.
- Vahidnezhad H, Youssefian L, Saeidian AH, Uitto J. Phenotypic spectrum of epidermolysis bullosa: the paradigm of syndromic versus non-syndromic skin fragility disorders. Journal of Investigative Dermatology. 2019;139(3):522-527.
- Sarkar R, Bansal S, Garg VK. Epidermolysis bullosa: where do we stand? Indian Journal of Dermatology, Venereology and Leprology. 2011;77(4):431-438.
- Posada C, Chen L, Alloo A, Burds A. Unusual skin findings: implications for diagnosis and management. Cleveland Clinic Journal of Medicine. 2019;86(6):381-388.
- Siegel DH, Ashton GH, Penagos HG, et al. Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. The American Journal of Human Genetics. 2003;73(1):174-187.
- Ghosh D, Dhali S, Ghosh AK, et al. Spectrum of uncommon skin adnexal tumors: a clinicopathological study. Indian Journal of Pathology and Microbiology. 2020;63(4):514-520.
- Sethuraman G, Marwaha RK, Challa A, et al. Diagnosing Langerhans cell histiocytosis: a clinicopathological study. Journal of Cutaneous Pathology. 2017;44(8):637-641.
- Coulombe PA, Lee CH. Defining keratin protein function in skin epithelia: epidermolysis bullosa simplex and its aftermath. Journal of Investigative Dermatology. 2012;132(3 Pt 2):763-775.
- Tang L, Cheng J. Nonpharmacological therapies for improving quality of life in patients with rare dermatologic conditions. Dermatologic Therapy. 2019;32(6):e13107.
- Castelo-Soccio L. Diagnosis and management of unusual pediatric skin disorders. Current Opinion in Pediatrics. 2018;30(4):518-526.
- Choi Y, Sims GE, Murphy S, Miller JR, Chan AP. Predicting the functional effect of amino acid substitutions and indels. PLoS One. 2012;7(10):e46688.
- Mosterd K, Arits AH, Nelemans PJ, Kelleners-Smeets NW. Aesthetic evaluation after non-invasive treatment for superficial basal cell carcinoma. Journal of the European Academy of Dermatology and Venereology. 2013;27(5):647-650.
- Tolkachjov SN, Brodland DG, Coldiron BM, et al. Understanding Mohs micrographic surgery: a review and practical guide for the nondermatologist. Mayo Clinic Proceedings. 2017;92(8):1261-1271.
- Yu L, Marshall CD, Wiet GJ, Huang Y. Tissue expansion and flap reconstruction in head and neck surgery. JAMA Facial Plastic Surgery. 2018;20(5):360-367.
- March OP, Reichelt J, Koller U. Gene therapy for rare skin diseases. Journal der Deutschen Dermatologischen Gesellschaft. 2019;17(4):317-327.
- Bauer JW, Koller J, Murauer EM, et al. Closure of a large chronic wound through transplantation of gene-corrected epidermal stem cells. Journal of Investigative Dermatology. 2017;137(3):778-781.
- De Luca M, Aiuti A, Cossu G, et al. Advances in stem cell research and therapeutic development. Nature Cell Biology. 2019;21(7):801-811.
